Homehealth sector stocks

health sector stocks

Biogen Inc. (BIIB) Gains As Market Dips: What You Should Know

Biogen Inc. (BIIB) Gains As Market Dips: What You Should Know

April 8, 2022

Esperion’s (ESPR) Drug Sales and Cost-Cutting Drive Stock YTD

Esperion’s (ESPR) Drug Sales and Cost-Cutting Drive Stock YTD

April 8, 2022

Iovance (IOVA) Stock Rallies 33% in a Month: Here’s Why

Iovance (IOVA) Stock Rallies 33% in a Month: Here’s Why

April 8, 2022

Top Stock Reports for Costco, AstraZeneca & Medtronic

Top Stock Reports for Costco, AstraZeneca & Medtronic

April 8, 2022

Investor Action Reminder: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm

Investor Action Reminder: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm

April 8, 2022

Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer

Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer

April 8, 2022

The Zacks Analyst Blog Highlights Bristol Myers, Vir Biotechnology, Gilead Sciences, and Vertex Pharmaceuticals

The Zacks Analyst Blog Highlights Bristol Myers, Vir Biotechnology, Gilead Sciences, and Vertex Pharmaceuticals

April 8, 2022

Zacks Investment Ideas feature highlights: Regeneron and Bristol-Myers Squibb

Zacks Investment Ideas feature highlights: Regeneron and Bristol-Myers Squibb

April 8, 2022

Bruker’s (BRKR) Buyout to Expand Mass Spectrometry Prospects

Bruker’s (BRKR) Buyout to Expand Mass Spectrometry Prospects

April 8, 2022

Antibody Treatments for COVD-19 Face Challenges in the U.S.

Antibody Treatments for COVD-19 Face Challenges in the U.S.

April 8, 2022

« 1 … 70 71 72 73 74 … 449 »